Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 466 AL 480

Clarithromycin-induced myoclonic status epilepticus

Biçimveren MS.

Pract Neurol. 2025 Sep 12;25(5):455-457. doi: 10.1136/pn-2024-004464.

[Progressive Myoclonus Epilepsy: Diversity of Disorders and Key Points in Clinical Practice]

Tojima M, Kobayashi K, Inoue H, Ikeda A.

Brain Nerve. 2025 May;77(5):615-626. doi: 10.11477/mf.188160960770050615.

Progressive encephalomyelitis with rigidity and myoclonus after thymectomy in a woman with myasthenia gravis

Qin L, Yan W.

Front Immunol. 2025 Apr 16;16:1563700. doi: 10.3389/fimmu.2025.1563700. eCollection 2025.

Myoclonus classification revisited: Introducing the biaxial model

Mahajan A, Espay AJ.

Parkinsonism Relat Disord. 2025 Mar;132:107296. doi: 10.1016/j.parkreldis.2025.107296. Epub 2025 Jan 21.

Inhaled sevoflurane use for myoclonic status secondary to bupropion intoxication

Canasiro AR, Park M, Cardozo Junior LCM, Vilar GR, Hajjar LA.

Crit Care Sci. 2025 Jul 11;37:e20250296. doi: 10.62675/2965-2774.20250296. eCollection 2025.

Review of Paraneoplastic Syndromes in Children with Malignancy

Mitur-Lesiuk M, Dubaj M, Raniewicz M, Bigosiński K, Dembowska-Kupień A.

Med Sci Monit. 2025 Mar 31;31:e947393. doi: 10.12659/MSM.947393.

Myoclonus After Cardiac Arrest: Need for Standardization-A Systematic Review and Research Proposal on Terminology

De Stefano P, Leitinger M, Misirocchi F, Quintard H, Degano G, Trinka E.

Crit Care Med. 2025 Feb 1;53(2):e410-e423. doi: 10.1097/CCM.0000000000006521. Epub 2024 Nov 22.

Lance-Adams syndrome or chronic post-hypoxic myoclonus in adults: a systematic literature review

Vellieux G, Apartis E, Navarro V.

Brain Commun. 2025 Sep 9;7(5):fcaf329. doi: 10.1093/braincomms/fcaf329. eCollection 2025.

One gene, many phenotypes: the role of KIF5A in neurodegenerative and neurodevelopmental diseases

Cozzi M, Tedesco B, Ferrari V, Chierichetti M, Pramaggiore P, Cornaggia L, Magdalena R, Brodnanova M, Mohamed A, Milioto C, Piccolella M, Galbiati M, Rusmini P, Crippa V, Gellera C, Magri S, Taroni F, Cristofani R, Poletti A.

Cell Commun Signal. 2025 Jun 16;23(1):287. doi: 10.1186/s12964-025-02277-x.

ILAE 2025 Classification of Epileptic Seizures: Key Revisions and Implications for Clinical Practice

Ragunathan K, Veeraraghavan V, Kaushik JS.

Indian Pediatr. 2025 Aug;62(8):623-627. doi: 10.1007/s13312-025-00120-7. Epub 2025 Jun 30.

Neurodevelopmental Disorder and Cortical Myoclonus in ZMYM2 Deficiency

Pollini L, Novelli M, Travaglini L, Panvino F, Leuzzi V, Pisani F, Galosi S.

Mov Disord. 2025 Dec;40(12):2839-2841. doi: 10.1002/mds.70056. Epub 2025 Sep 24.

Milestone Review: Unlocking the Proteomics of Glycine Receptor Complexes

Fraser SD, Klaassen RV, Villmann C, Smit AB, Harvey RJ.

J Neurochem. 2025 Apr;169(4):e70061. doi: 10.1111/jnc.70061.

Lance-Adams Syndrome: An Updated Review of a Rare Post-Hypoxic Complication

Malakooti M, Heidari A, Motieian M, Farid A, Neshat S, Bidares M, Jahanshahi F, Gorgani M, Shayestehyekta H, Moradi H, Valipoor A.

Tremor Other Hyperkinet Mov (N Y). 2025 Sep 24;15:45. doi: 10.5334/tohm.1074. eCollection 2025.

Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor Antibodies: Clinical Features and Outcomes

Guasp M, Saiz A, Ruiz-Vives M, Almendrote M, Bruna J, González-Menacho J, Kaneko J, Martín-Aguilar L, Martínez-García FA, Noda K, Ruiz Molina A, Sequeiros S, Simabukuro MM, Takenaka M, Zurdo M, Dalmau JO, Iizuka T, Graus F.

Neurol Neuroimmunol Neuroinflamm. 2025 Nov;12(6):e200473. doi: 10.1212/NXI.0000000000200473. Epub 2025 Sep 15.

Etomidate and its derivatives: time to say goodbye?

Sneyd JR, Valk BI.

Br J Anaesth. 2025 Jan;134(1):11-13. doi: 10.1016/j.bja.2024.09.011. Epub 2024 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias